Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × Bronchoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 21 Carcinoma, Non-Small-Cell Lung 5 Pulmonary Disease, Chronic Obstructive 2 Pneumonia 2 Neoplasms 2 Lung Diseases 2 Laryngeal Neoplasms 2 Hemoptysis 2 Tuberculosis 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pulmonary Nodule Cm 1 Pulmonary Fibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Lung Diseases, Obstructive 1 Lung Diseases, Interstitial 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Infections 1

Interventions

Carboplatin 11 Pemetrexed 7 pembrolizumab 4 Paclitaxel 4 Cisplatin 4 durvalumab 3 Radiosurgery 3 selpercatinib 2 pralsetinib 2 osimertinib 2 atezolizumab 2 Gemcitabine 2 taletrectinib 1 repotrectinib 1 motexafin gadolinium 1 exemestane 1 entinostat 1 ceralasertib 1 cemiplimab 1 camrelizumab 1 belinostat 1 belagenpumatucel L 1 alectinib 1 Tyrosine Kinase Inhibitors 1 TNFSF10 protein, human 1 Radiotherapy 1 Platinum Compounds 1 Patient Reported Outcome Measures 1 Oncolytic Virotherapy 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡